SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-006809
Filing Date
2023-09-28
Accepted
2023-09-28 16:41:35
Documents
12
Period of Report
2023-09-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm   iXBRL 8-K 40430
  Complete submission text file 0001683168-23-006809.txt   215636

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE snoa-20230922.xsd EX-101.SCH 3027
3 XBRL LABEL FILE snoa-20230922_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE snoa-20230922_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3299
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 231290365
SIC: 2834 Pharmaceutical Preparations